Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells. 

Biotechnology

Vor Biopharma

Robert Ang

John Lydeard

Kevin McEvoy

Kerry Chios

Brian Bellesheim

Amy Quinlan

David Phillips

Deborah Lloyd

Sarah Spencer

Gary G.

Eyal Attar

John King

Tirtha Chakraborty

Tania Philipp

Scientific Research Team

Engineering and Development Team

Clinical Operations Team

Leadership Team

Regulatory Affairs and Quality Assurance Team

Finance and Accounting Team

Human Resources and Talent Acquisition Team

Teams at Vor Biopharma